Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
BACKGROUND: Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of this increased risk has not been widely studied. OBJECTIVE: To evaluate the contribution of the underlying disease...
Main Authors: | de Vries, F, Pouwels, S, Lammers, J, Leufkens, H, Bracke, M, Cooper, C, van Staa, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
by: de Vries, F, et al.
Published: (2007) -
Fracture risk with intermittent high-dose oral glucocorticoid therapy.
by: De Vries, F, et al.
Published: (2007) -
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
by: Pouwels, S, et al.
Published: (2009) -
Use of beta-2 agonists and risk of hip fracture
by: De Vries, F, et al.
Published: (2006) -
Risk of hip/femur fracture after stroke: a population-based case-control study.
by: Pouwels, S, et al.
Published: (2009)